TPS5609 A phase 2, open-label study of niraparib in women with advanced, relapsed, high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer after ≥3 previous chemotherapy regimens Kathleen N.

First Page		Document Content
Date: 2015-06-03 16:43:13		TPS5609 A phase 2, open-label study of niraparib in women with advanced, relapsed, high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer after ≥3 previous chemotherapy regimens Kathleen N. Add to Reading List Source URL: www.tesarobio.com Download Document from Source Website File Size: 823,62 KB Share Document on Facebook